Discontinued — last reported Q4 '23
Cardinal Health Pharmaceutical — Total Assets increased by 7.1% to $31.02B in Q4 2023 compared to the prior quarter. Year-over-year, this metric grew by 7.0%, from $28.99B to $31.02B. Over 2 years (FY 2021 to FY 2023), Pharmaceutical — Total Assets shows an upward trend with a 9.8% CAGR.
An increase suggests capital expansion or inventory buildup, while a decrease may indicate divestitures or improved asset utilization.
This metric measures the total value of resources controlled by the pharmaceutical segment, including inventory, account...
Comparable to other capital-intensive distribution businesses that require significant investment in logistics and inventory management.
cah_segment_pharmaceutical_total_assets| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $23.62B | $23.96B | $24.43B | $25.47B | $26.41B | $27.25B | $28.99B | $27.95B | $28.08B | $28.97B | $31.02B |
| QoQ Change | — | +1.4% | +2.0% | +4.3% | +3.7% | +3.2% | +6.4% | -3.6% | +0.4% | +3.2% | +7.1% |
| YoY Change | — | — | — | — | +11.8% | +13.8% | +18.7% | +9.8% | +6.3% | +6.3% | +7.0% |